EIDOS THERAPEUTICS, INC. Assets, Fair Value Disclosure
EIDOS THERAPEUTICS, INC. had Assets, Fair Value Disclosure of $147.33 million as of 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2020-10-29
- 2020-09-30: Assets, Fair Value Disclosure $147.33M.
- 2020-06-30: Assets, Fair Value Disclosure $174.82M.
- 2020-03-31: Assets, Fair Value Disclosure $196.51M.
- 2019-12-31: Assets, Fair Value Disclosure $191.16M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2020-09-30 | $147.33M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $174.82M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $196.51M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $191.16M 10-Q · filed 2020-10-29 |
| 2019-09-30 | $165.82M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $131.40M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $147.06M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $157.15M 10-Q · filed 2019-10-31 |